Ikarian Capital, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Ikarian Capital, LLC disclosed 96 US equity positions worth $322.0m in its Q3 2024 13F filing. The largest position was TARS at 10.5% of the reported book, followed by CRNXGBP and ELVN.
What did Ikarian Capital, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 10.5% | $33.9m | 1,030,277 | – | |
| 2 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 6.8% | $21.8m | 426,913 | – | ||
| 3 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 4.0% | $12.8m | 499,566 | – | |
| 4 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 3.5% | $11.4m | 744,000 | – | |
| 5 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.5% | $11.4m | 499,977 | – | |
| 6 | INSM INSMED INC | Healthcare | 3.5% | $11.3m | 154,835 | – | |
| 7 | SLNOEUR SOLENO THERAPEUTICS INC | 3.5% | $11.2m | 221,437 | – | ||
| 8 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.1% | $9.9m | 179,000 | – | |
| 9 | AVTX AVALO THERAPEUTICS INC | Healthcare | 2.9% | $9.2m | 970,359 | – | |
| 10 | CYTK CYTOKINETICS INC | Healthcare | 2.8% | $9.0m | 170,147 | – | |
| 11 | SYRE SPYRE THERAPEUTICS INC | 2.8% | $8.9m | 302,247 | – | ||
| 12 | CATALYST PHARMACEUTICALS INC | 2.6% | $8.3m | 417,850 | – | ||
| 13 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 2.5% | $8.1m | 267,145 | – | |
| 14 | 2655787D BLUEPRINT MEDICINES CORP | 2.4% | $7.9m | 85,000 | – | ||
| 15 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.3% | $7.3m | 285,613 | – | |
| 16 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.1% | $6.8m | 54,176 | – | |
| 17 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.8% | $5.9m | 284,715 | – | |
| 18 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.8% | $5.8m | 260,000 | – | |
| 19 | NUVALENT INC | 1.7% | $5.3m | 52,238 | – | ||
| 20 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.6% | $5.1m | 115,200 | – | |
| 21 | RLAY RELAY THERAPEUTICS INC | Healthcare | 1.5% | $4.9m | 693,350 | – | |
| 22 | LENZ LENZ THERAPEUTICS INC | Healthcare | 1.5% | $4.9m | 204,513 | – | |
| 23 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 1.4% | $4.6m | 300,000 | – | |
| 24 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.4% | $4.5m | 544,265 | – | |
| 25 | RZLT REZOLUTE INC | 1.3% | $4.3m | 887,230 | – | ||
| 26 | AMGN AMGEN INC | Healthcare | 1.3% | $4.3m | 13,300 | – | |
| 27 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.3% | $4.2m | 107,187 | – | |
| 28 | EOLS EVOLUS INC | Healthcare | 1.3% | $4.2m | 258,279 | – | |
| 29 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 1.1% | $3.7m | 583,593 | – | |
| 30 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 1.1% | $3.6m | 197,096 | – | |
| 31 | PYXS PYXIS ONCOLOGY INC | 1.1% | $3.5m | 957,408 | – | ||
| 32 | SLN SILENCE THERAPEUTICS PLC | 1.0% | $3.4m | 587,343 | – | ||
| 33 | ACELYRIN INC | 1.0% | $3.3m | 677,074 | – | ||
| 34 | HELP CYBIN INC | 1.0% | $3.3m | 367,195 | – | ||
| 35 | CRVO CERVOMED INC | 0.9% | $3.0m | 202,345 | – | ||
| 36 | TRML TOURMALINE BIO INC | 0.9% | $2.8m | 108,483 | – | ||
| 37 | 430 TERNS PHARMACEUTICALS INC | 0.8% | $2.6m | 308,497 | – | ||
| 38 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.7% | $2.4m | 8,741 | – | |
| 39 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.7% | $2.3m | 257,216 | – | |
| 40 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.7% | $2.2m | 180,000 | – | |
| 41 | RENEO PHARMACEUTICALS INC | 0.5% | $1.7m | 1,025,668 | – | ||
| 42 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.5% | $1.7m | 1,312,405 | – | |
| 43 | GLUE MONTE ROSA THERAPEUTICS INC | 0.5% | $1.7m | 311,593 | – | ||
| 44 | ONC BEIGENE LTD | Healthcare | 0.5% | $1.6m | 88,167 | – | |
| 45 | 698 ACHILLES THERAPEUTICS PLC | 0.5% | $1.5m | 1,443,181 | – | ||
| 46 | IBIO IBIO INC | 0.4% | $1.3m | 600,000 | – | ||
| 47 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.4% | $1.3m | 202,908 | – | |
| 48 | KOD KODIAK SCIENCES INC | Healthcare | 0.4% | $1.2m | 476,586 | – | |
| 49 | MRNS* MARINUS PHARMACEUTICALS INC | 0.4% | $1.2m | 706,154 | – | ||
| 50 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.4% | $1.2m | 100,609 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.